首页> 外文期刊>Veterinary Microbiology >B cell cross-epitope of Propionibacterium acnes and Actinobacillus pleuropneumonia selected by phage display library can efficiently protect from Actinobacillus pleuropneumonia infection
【24h】

B cell cross-epitope of Propionibacterium acnes and Actinobacillus pleuropneumonia selected by phage display library can efficiently protect from Actinobacillus pleuropneumonia infection

机译:B细胞串联痤疮丙酸杆菌和Actinobacillus的胸膜肺炎,噬菌体展示库中选择的胸膜肺炎可以有效地保护Actinobacillus胸膜炎感染

获取原文
获取原文并翻译 | 示例
       

摘要

Contagious porcine pleuropneumonia (CPP), caused by Actinobacillus pleuropneumoniae (APP), is a highly transmissible and fatal respiratory illness that causes tremendous economic losses for the pig breeding industry worldwide. Propionibacterium acnes (PA) has a strong cross-reaction with anti-APP1 and anti-APP5 serum and can efficiently prevent APP infection, which was fortuitously found in researching the differential gene between the different APP serotypes. There seems to be some natural cross-protection between PA and APP. To identify the common epitope, the phage display library of a PA whole genome was constructed, whose size is 10(5). The DNA sequence of the positive clone was determined after three rounds of biopanning, and ten common protein types were identified and the epitope was predicted by computer software. Six peptide epitopes were selected and synthesized for further analysis. Among these epitopes, Ba1, Bb5 and C1 could bind to anti-PA serum and anti-APP1 serum and vice versa. Furthermore, the IgG and IL-4 levels and CD4(+)/CD8(+) T cell ratios in the Ba1, Bb5 and Cl groups were significantly higher than that in the control group, indicating that the epitopes could trigger an immune response, which was mainly humoral immunity. Moreover, Ba1 and Bb5 equally protected 80% of mice from a fatal dose of APP1 infection compared with the control group. Mice could resist APP1 and APPS challenge after being treated with the combination of Ba1 and Bb5, with survival rates of 80% and 90%, respectively. These findings suggest that the PA epitope confers antigenicity and can heterologously resist to the APP infection. This finding provides a novel strategy for preventing APP infection.
机译:由Actinobacillus胸膜炎(APP)引起的传染性猪胸膜炎(CPP)是一种高度传播和致命的呼吸道疾病,导致全球猪养殖业的经济损失巨大。丙酮(PA)丙酸杆菌(PA)具有与抗APP1和抗APP5血清的强烈交叉反应,可有效预防应用感染,这是偶然发现在研究不同APP血清型之间的差异基因。 PA和APP之间似乎有一些自然的交叉保护。为了鉴定常见的表位,构建了PA全基因组的噬菌体显示文库,其尺寸为10(5)。在三轮生物丙戊烷中测定阳性克隆的DNA序列,并鉴定了十种常见的蛋白质类型,并且计算机软件预测表位。选择并合成六种肽表位以进一步分析。在这些表位,BA1,BB5和C1可以与抗PA血清和抗APP1血清结合,反之亦然。此外,BA1,BB5和Cl组中的IgG和IL-4水平和CD4(+)/ CD8(+)T细胞比显着高于对照组中的,表明表位可能引发免疫应答,这主要是体液免疫力。此外,与对照组相比,BA1和BB5同等地保护80%的APP1感染的小鼠。小鼠可以在用BA1和BB5的组合治疗后抵抗APP1和APPS挑战,分别存在80%和90%的存活率。这些发现表明PA表位赋予抗原性,并且可以异常抵抗APP感染。该发现提供了一种预防应用感染的新策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号